Ligand Pharmaceuticals (LGND)

Ligand Pharmaceuticals (LGND)

Postby winston » Thu Jun 16, 2016 9:25 am

not vested

Ligand Pharmaceuticals Inc. (NASDAQ: LGND)

by: Christian Tharp, CMT

Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing and acquiring technologies that help pharmaceutical companies discover and develop medicines worldwide.

Its commercial programs include Promacta, an oral medicine that increases the number of platelets in the blood; Kyprolis that is used for the treatment of multiple myeloma; bazedoxifene, which is used for the treatment of postmenopausal osteoporosis; Nexterone, a Captisol-enabled formulation of amiodarone; Noxafil-IV, a Captisol-enabled formulation of posaconazole for IV use; Exemptia for autoimmune diseases; and Vivitra for breast cancer.

Source: Today's Big Stock

http://todaysbigstock.com/2016/06/15/li ... sdaq-lgnd/
It's all about "how much you made when you were right" & "how little you lost when you were wrong"
User avatar
winston
Billionaire Boss
 
Posts: 118539
Joined: Wed May 07, 2008 9:28 am

Return to L to R

Who is online

Users browsing this forum: No registered users and 9 guests

cron